- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Dotinurad, as a uric acid excretion enhancer, has contraindications mainly related to severe renal insufficiency, allergic reactions, and speci...
Dotinurad, as a uric acid excretion enhancer, can be used for long-term treatment of gout/hyperuricemia under the guidance of a physician, but ...
As a AIDS compound preparation, Triumeq can be taken for a long time under the guidance of professional doctors, but its efficacy and safety ne...
Suimeikai (Triumeq) is a AIDS compound preparation developed by GlaxoSmithKline, which contains three antiretroviral drugs: Dotiravir, Abacavir...
Trelagliptin, as the world's first weekly oral DPP-4 inhibitor, has been on the market for different periods of time depending on the country a...
As a long-acting DPP-4 inhibitor, the duration of administration of Trelagliptin has a significant impact on the efficacy of the drug. This m...
As an antidiabetic drug of DPP-4 inhibitor, the marketing of Tregliptin in China is the focus of attention of diabetes patients. According to t...
Trelagliptin, as a long-acting DPP-4 inhibitor, has the characteristics of both fixed and flexible medication time. It is necessary to arrange ...
Treagliptin is a long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor, which is mainly used for the treatment of type 2 diabetes. It has the co...
Tregliptin is a long-acting DPP-4 inhibitor, which is used for the treatment of type 2 diabetes. It is necessary to pay attention to the key in...
